Saudi Arabia Opens Borders to Visitors Vaccinated With Sputnik V

The jab based on a well-studied human adenovirus vector platform has been approved for use in 71 countries with a total population of 4 billion people. A comparative study of five vaccines conducted in Hungary showed that Sputnik V has the highest efficacy (98 percent) against preventing COVID-19-linked mortality.